Newsroom

APRIL 26 2021 Christine Hall Glytec is developing software that aims to set the standard for insulin dosing and glycemic management in hospitals. On Monday, the company brought in a new round of $21 million in equity and debt financing. More than 34 million Americans today live with diabetes, while 88 million live with prediabetes and over one-third of all patients — regardless of a diabetes...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens,...

APRIL 26 2021 Steven Loeb The company uses real-time data to ensure that hospitals give patients the right level of insulin A lot of people in America have diabetes and prediabetes, but even those who don't are likely to require insulin while they are staying in a hospital. The problem is that hospitals haven't invested in computerized protocols to deliver personalized dosing regimens, meaning...

APRIL 27 2021 Dennis Dailey Funding from Silicon Valley Bank and Savitr Capital Fuels Growth and Accelerates Innovation to Address Glycemic Management Challenges at Vast Majority of Hospitals Glytec, a provider of insulin management software across the continuum of care, announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding...

APRIL 26, 2021 Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing. The financing included: $9m debt financing from SVB, and $12m equity investment led by Savitr Capital and other private investors. The company intends to use the funds to invest in research and development around patient safety, provider workflows and...

WALTHAM, MASS. (April 26, 2021) – Glytec, the only provider of insulin management software across the continuum of care, today announced $21 million in financing from Silicon Valley Bank (SVB), Savitr Capital and other private investors. The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department. The combined $9 million...

APRIL 2021 Derek Bagley A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory University in Atlanta, write that...

APRIL 12, 2021 The Medical Design Excellence Awards competition is the medical technology industry's premier awards program. Since 1998, the MDEAs have recognized achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Each year, a panel of jurors comprised of designers, engineers, and clinicians awards bronze, silver, gold, and...

APRIL 2021 Derek Bagley Recently, Metro Health – University of Michigan Health, an affiliate of University of Michigan Health, announced that it reduced incidence of hypoglycemia by more than 54% and experienced a 40% decline in hyperglycemia since implementing personalized insulin dosing software. Glytec is marketing the software as the eGlycemic Management System® (eGMS). Extensive research...

MARCH 30 2021 Sean Whooley Glytec announced today that it introduced the latest version of its eGlycemic Management System (eGMS) for managing insulin. Waltham, Mass.-based Glytec’s eGMS is centered around the FDA-cleared Glucommander algorithm, which leverages real-time and historical data to recommend insulin dosing by learning each patient’s insulin sensitivity and anticipating future...